Table 3.
Predictors of severity as measured by a composite endpoint of admission to the intensive care unit, hospitalization >5 days, oxygen requirements, or death
| Univariable analysis | Multivariable analysis | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P value | OR | 95% CI | P value | |
| HRV/ENT versus RSV | 2·9 | 1·7, 5·1 | <0·001 | 1·7 | 0·9, 3·2 | 0·082 |
| HRV/ENT versus FLU | 3·6 | 2·0, 6·4 | <0·001 | 3·0 | 1·6, 5·6 | 0·001 |
| HRV/ENT versus others | 2·6 | 1·4, 4·9 | 0·003 | 1·8 | 0·9, 3·6 | 0·094 |
| Age | 1·1 | 1·0, 1·1 | 0·005 | 1·0 | 1·0, 1·1 | 0·180 |
| Cardio-respiratory | 2·7 | 1·6, 4·6 | <0·001 | 2·2 | 1·2, 4·0 | 0·007 |
| Prematurity | 1·2 | 0·6, 2·6 | 0·657 | – | – | – |
| Immunocompromised Metabolic | 5·3 | 3·2, 8·7 | <0·001 | 4·7 | 2·8, 8·0 | <0·001 |
HRV/ENT, enterovirus/rhinovirus; RSV, respiratory syncytial virus; FLU, influenza; others: PIV, parainfluenza; hMPV, human meta-pneumovirus; ADV, adenovirus, coronaviruses, HBoV.
Values indicated in bold were considered as significant P < 0.05.